These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21387786)

  • 1. [The review of acute risperidone poisoning].
    Ciszowski K; Szpak D; Wilimowska J
    Przegl Lek; 2010; 67(8):602-5. PubMed ID: 21387786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxicity of sulpiride].
    Ciszowski K; Szpak D; Wilimowska J
    Przegl Lek; 2010; 67(8):606-9. PubMed ID: 21387787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response.
    Lostia AM; Mazzarini L; Pacchiarotti I; Lionetto L; De Rossi P; Sanna L; Sani G; Kotzalidis GD; Girardi P; Simmaco M; Tatarelli R
    Ther Drug Monit; 2009 Aug; 31(4):475-81. PubMed ID: 19531984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone.
    Cohen LJ
    Pharmacotherapy; 1994; 14(3):253-65. PubMed ID: 7524043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolism.
    Schoretsanitis G; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Schizophr Res; 2017 Jul; 185():51-57. PubMed ID: 27993531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical picture of acute olanzapine poisonings].
    Ciszowski K; Sein Anand J; Wilimowska J; Jawień W
    Przegl Lek; 2011; 68(8):426-33. PubMed ID: 22010430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy.
    Paulzen M; Haen E; Hiemke C; Stegmann B; Lammertz SE; Gründer G; Schoretsanitis G
    Br J Clin Pharmacol; 2017 Aug; 83(8):1668-1675. PubMed ID: 28160505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?
    Schoretsanitis G; Haen E; Hiemke C; Gründer G; Stegmann B; Schruers KR; Veselinovic T; Lammertz SE; Paulzen M
    Int Clin Psychopharmacol; 2016 Sep; 31(5):259-64. PubMed ID: 27167902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism and excretion of risperidone after oral administration in rats and dogs.
    Meuldermans W; Hendrickx J; Mannens G; Lavrijsen K; Janssen C; Bracke J; Le Jeune L; Lauwers W; Heykants J
    Drug Metab Dispos; 1994; 22(1):129-38. PubMed ID: 7512019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic patterns of risperidone-associated adverse drug reactions.
    Schoretsanitis G; Stegmann B; Hiemke C; Gründer G; Schruers KR; Walther S; Lammertz SE; Haen E; Paulzen M
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1091-8. PubMed ID: 27376639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of risperidone in different application forms - Comparing long-acting injectable and oral formulations.
    Schoretsanitis G; de Leon J; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):130-137. PubMed ID: 29153926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of fatal risperidone poisoning alerts physicians.
    Hitosugi M; Tsukada C; Yamauchi S; Nagai T
    J Clin Psychopharmacol; 2014 Apr; 34(2):268-9. PubMed ID: 24525652
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.
    Vanwong N; Prommas S; Puangpetch A; Hongkaew Y; Nuntamool N; Nakorn CN; Ngamsamut N; Limsila P; Sukasem C
    J Clin Lab Anal; 2016 Nov; 30(6):1236-1246. PubMed ID: 27346210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis.
    Paulzen M; Haen E; Stegmann B; Hiemke C; Gründer G; Lammertz SE; Schoretsanitis G
    Psychoneuroendocrinology; 2016 Nov; 73():9-15. PubMed ID: 27448523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.
    Jung SM; Kim KA; Cho HK; Jung IG; Park PW; Byun WT; Park JY
    Clin Pharmacol Ther; 2005 Nov; 78(5):520-8. PubMed ID: 16321618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting serum risperidone concentrations.
    Boerth JM; Caley CF; Goethe JW
    Pharmacotherapy; 2005 Feb; 25(2):299-302. PubMed ID: 15767244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.
    Paulzen M; Haen E; Stegmann B; Unterecker S; Hiemke C; Gründer G; Schoretsanitis G
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):325-333. PubMed ID: 27695935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.